Latest filing published 07 Jul 2014 for Furiex Pharmaceuticals, Inc..
No signal scores available.
Sailash Patel discloses dealings in Furiex Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 15 November 2013 to 2 July 2014, the count stands at 6 filings.
On the market, this insider has only sold: 2 sales, €2.6M in total. The rest of the record consists of 2 share grants and 1 option exercise. In 2014 alone, the filings show no purchases and 2 sales.
The record was last updated on 7 July 2014 with a transaction in Furiex Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations